<template>
    <div class="dark:bg-slate-900 min-h-screen text-slate-800 dark:text-slate-400">
        <div class="">
            <div class="flex flex-col justify-center h-80 lg:h-96 bg-layeredpeaks">
                <div class="text-left text-4xl 2xl:text-6xl font-semibold px-4 lg:px-10 xl:px-24 2xl:px-30">
                    <p>About</p>
                </div>
            </div>
            <div class="px-4 lg:px-10 xl:px-24 2xl:px-30 font-light text-lg lg:text-xl">
                <img src="/images/pallid.jpg" class="float-right ml-6 mb-6 w-48 lg:w-72 2xl:w-80 object-cover shadow-lg shadow-slate-400"></img>
                <p class="text-left">
                    I am broadly interested in how viruses evolve in wild mammals, in particular bats and rodents. I am currently a postdoctoral fellow at the <a class="text-blue-400 hover:text-blue-600" href="https://www.fredhutch.org/en.html">Fred Hutch Cancer Center</a>, in Seattle, Washington, where I study Nipah virus in the <a class="text-blue-400 hover:text-blue-600" href="https://research.fredhutch.org/bloom/en.html">Bloom lab</a>.
                </p>
                <p class="text-left">
                    I received my PhD in 2021 from the University of Arizona in Tucson, Arizona, in the <a class="text-blue-400 hover:text-blue-600" href="https://eeb.arizona.edu">Department of Ecology and Evolutionary Biology</a>. I worked with my PhD advisor, Dr. Michael Worobey, to study the evolution of paramyxoviruses in wild mammals and the spread of SARS-CoV-2 during the early stages of the pandemic.
                </p>
                <img src="/images/1232541671.jpg" class=""></img>
                <p class="text-left">
                    Prior to my PhD, I worked as a research technician in the lab of <a class="text-blue-400 hover:text-blue-600" href="https://mullinslab.microbiol.washington.edu/people/faculty/1460-James-Mullins">Dr. James Mullins</a> at the University of Washington, in Seattle, Washington. I worked on projects that involved sequencing HIV genomes from breakthrough infections in vaccine trials and early infection.
                </p>
            </div>
        </div>
    </div>
</template>


